Patrick Sullivan, DVM, PhD

Funding cuts for research intended to make treatment and cures available and accessible for patients with HIV could affect HIV care in the long term.

Several actions taken by the current administration may affect the landscape of prevention of HIV, prompting an analysis of these effects.

Any potential reduction in access to pre-exposure prophylaxis (PrEP) would increase both cost and the number of diagnoses of HIV.